October Consortium Agreement Signals End to HIP 87621 Enclave Conflict

An agreement has reportedly been reached between October Consortium and a coalition of the remaining Powers within the enclave, ending large-scale hostilities in the region.

The “October Accords” formally places HIP 87621 under the custodianship of October Consortium who will act as chair between the remaining enclave powers to ensure neutrality is maintained.

Under the terms, the corporation will also retain responsibility for system security and commercial rights, with authority to defend those interests if challenged.

The talks are also understood to have focused on shared scientific access to Radicoida unica and cooperation on research initiatives following the recent publication of promising genetic findings by Dr Casimir of the Holloway Bioscience Institute.

The coalition involved – an informal alignment of Imperial, Alliance and independent Power forces – had recently announced a non-aggression pact intended to prevent further escalation in the enclave.

Analysts suggest the arrangement had created space for diplomatic settlement rather than decisive military resolution, with no single power claiming majority control over the enclave.

Sources close to the recent discussions confirmed that the Federation was not represented, having lost its foothold in the enclave during the opening stages of the conflict. President Felicia Winters was unavailable for comment.

In the past months, the powers ejected from enclave conflict have increased their offensive activity within the core systems against the remaining enclave Powers. Analysts have concluded that a rapid diplomatic ending to the enclave conflict was required to allow redeployment of forces to defend against this aggression.

The rise of Lexi October and the growing influence of October Consortium since the discovery of Radicoida unica has not gone unnoticed, however, and Vox Galactica has confirmed that an interview with the Consortium’s reclusive chief executive has been secured for an upcoming feature series.